Particella
Oral Gene Medicines
Operating in biopharma based in United States, Particella was founded in 2016.
Profile
Particella Inc., (formerly DNAlite Therapeutics) is a biotechnology company that has developed a novel proprietary lipid nanoparticle that can deliver mRNA and other nucleic acids orally.
As a business in biopharma, Particella is listed here with the public details available about it.
United States is where the company is located.
The company is listed at the SOSV portfolio company stage of development.
Its team size is recorded as 2-10 employees.
| Sector | Biopharma |
|---|---|
| Country | United States |
| Founded | 2016 |
| Employees | 2-10 |
| Stage | SOSV portfolio company |
Website: particella.bio
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account